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INTRODUCTION
Rupture of membrane, especially in preterm cases,
is associated with infections and adverse neonatal
outcomes.1,2 Review by Teune et al on 29,375,675
infants found that outcomes such as respiratory
distress, intraventricular hemorrhage and death
were larger in preterm infants.3 Spontaneous
membrane rupture occurred in 35% of 27,771 late
preterm births at Parkland hospital.4 Incidence of
preterm birth in Dr. Cipto Mangunkusumo hospital
from January till December 2011 was between 5
to 15%. Survival rate for infants born within 28 to
32 weeks gestational age was 65.8% to 77.6% in
our hospital (unpublished data). Granovsky found
that preterm and small for gestational age infants
were even at more risk for developing retinopathy,
bronchopulmonary dysplasia, necrotizing entero-
colitis and death.5
Abstract
Objective: We aimed to do a study in the use of the identification of
Placental Alpha Micro Globulin-1 or PAMG-1, in the form of Am-
nisure® test, as a method to diagnose rupture of membrane (ROM),
compared with other conventional method (direct visualization and
nitrazine test).
Method: We used a cross-sectional design. Every pregnant woman
who came to our hospital with gestational age of 14 to 42 weeks
complaining of membrane rupture was recruited. Sterile speculum
examination and nitrazine test was performed for every patient. Am-
nisure® was utilized, using vaginal swab from posterior fornices.
Data analysis was performed with SPSS version 17.
Results: We recruited 20 patients to join our study. Mean age, parity
and gestational age was 28.5 years, parity one and 35.5 ± 3.4 weeks
of gestation. Amnisure® test was positive in 14 patients. With ni-
trazine as standard for ROM diagnosis, the sensitivity for Amnisure®
was 85% and the specificity was 83.3%. The positive predictive
value was 92.3% and negative predictive value was 71.4%.
Conclusion: For every positive vaginal pooling, nitrazine and Am-
nisure® will be tested positive. Several studies using Amnisure®
have shown similar results. Role of Amnisure® seemed evident in
cases of uncertainty such as chronic ROM and severe oligohydram-
nios due to ROM. Positive results in presence of intact membranes
which suggested micro-perforations of the membrane still need fur-
ther research. Much still needed to be done before implementing
Amnisure® in our country, especially in the matter of cost effective-
ness.
[Indones J Obstet Gynecol 2012; 36-1:20-3]
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Abstrak
Tujuan: Mengadakan penelitian untuk menguji metode deteksi
ketuban pecah menggunakan Placental Alpha Micro Globulin-1 (Am-
nisure®) dibandingkan dengan metode konvensional (tes valsava dan
tes lakmus/tes nitrazin).
Metode: Penelitian ini merupakan studi potong lintang. Setiap wanita
hamil yang datang ke rumah sakit kami dengan usia gestasi 14 hingga
42 minggu dan keluhan ketuban pecah diikutkan dalam penelitian.
Pemeriksaan spekulum steril untuk melihat tes valsava dan tes lakmus
dilakukan pada setiap pasien. Tes Amnisure® dilakukan dengan
apusan dari forniks posterior. Analisis data dilakukan dengan SPSS
versi 17.
Hasil: Sebanyak 20 pasien diikutsertakan dalam studi kami. Rerata
usia, paritas dan usia gestasi adalah 28,5 tahun, paritas satu dengan
usia gestasi 35,5 ± 3,4 minggu. Tes Amnisure® positif pada 14 pasien.
Dengan tes lakmus sebagai standar bagi diagnosis ketuban pecah,
sensitivitas Amnisure® adalah 85%, spesifisitas 83,3%. Nilai prediksi
positif dan negatif adalah 92,3% dan 71,4%.
Kesimpulan: Untuk setiap tes valsava positif, nilai positif akan di te-
mukan pada tes lakmus dan tes Amnisure®. Beberapa studi menggu-
nakan Amnisure® menunjukkan hasil serupa. Peran Amnisure® tam-
paknya jelas pada kasus sulit seperti ketuban pecah kronik, oligo-
hidramnion berat karena ketuban pecah. Hasil positif dalam keadaan
selaput membran intak, yang menandakan adanya mikro-perforasi
memerlukan penelitian tambahan. Studi lebih lanjut diperlukan se-
belum mengimplementasikan penggunaan Amnisure® di Indonesia,
terutama jika menyangkut isu tentang efektivitas biaya.
[Maj Obstet Ginekol Indones 2012; 36-1:20-3]
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Membrane rupture was associated with inflam-
mation, proven by positive amniotic culture in 32
to 35% patients.6 Presence of membrane rupture
will determine further management of the pa-
tient.7-9 Thus, we need to stress out the importance
of firm diagnosis of this condition in every day
practice. Several markers for infection has been es-
tablished8-10 Kiefer et al proposed an amniotic in-
flammatory score to predict preterm parturition
syndrome.8 Agustin and Romero assessed the
value of fetal fibronecton as predictor for sponta-
neous preterm delivery in multiple gestations.9
Sarah Lee et al measured level of interleukin-6
trans signaling molecule soluble GP130 and soluble
IL-6 receptor in amniotic fluid of women with pre-
term rupture of membranes and signs of inflam-
mation.10
Establishment or membrane rupture can be
done by several methods. Visualization by vaginal
pooling at posterior fornices, nitrazine test, and
fern test are some examples. According to the
guidelines from Royal College of Obstetricians and
Gynecologist, the diagnosis is best made by history
suggestive of membrane rupture, followed by dem-
onstration of fluid pooling.11 However, in cases in
which these conditions are not met, other test
might be helpful.12 Identification of Placental Alpha
Micro Globulin-1 (PAMG-1) is a novel method for
diagnosis of membrane rupture. In this study, we
present our preliminary results of comparison be-
tween Amnisure® test with other conservative test
in management for membrane rupture.
METHODS
Every pregnant woman with gestational age from
14 weeks up to 42 weeks gestational age and chief
complaints of membrane rupture who came to our
hospital were asked to participate in our study.
Gestational age was determined by addressing last
menstrual period, and/or data from earliest ultra-
sound findings, combined with clinical and ultra-
sound result at present. History taking from the pa-
tient will ask whether she felt her membrane rup-
tured/not, sensation of water leaking out from her
and duration of this feeling.
Every woman will undergo sterile speculum ex-
amination. Presence or absence of vaginal pooling
at posterior fornices is assessed for each patient.
Swabs of the posterior fornices was taken twice for
nitrazine test and Amnisure® test. For nitrazine
test, we used standard dipstick for pH determina-
tion. Positive nitrazine test was determined when
pH level of vaginal fluid/secretion was alkaline. A
swab for Amnisure® was taken and agitated in di-
luents vial, which contain 0.9% NaCl, 0.01% Triton
X100, 0.05% NaN3, for one minute. The test strip
was then dipped directly to the diluents vial,
achieving the results within ten minutes, as shown
in Figure 1. Two strips indicated positive results
for membrane rupture. Diagnosis of membrane
rupture was based on history taking, sterile spe-
culum examination and nitrazine result. Standard
for diagnosis of rupture of membrane on our hos-
pital was the combination of these three findings.
We have yet to adopted Amnisure® as our stand-
ard of diagnostic method.
Data analysis after completion of sample taking
was conducted with Statistical Package for Social
Science (SPSS Inc) Version 17.0. The mean, sensi-
tivity and specificity were measured. Tabulation of
data was performed as well and presented herein.
RESULT
This was a preliminary study, with as many as
twenty patients participated in this research. Com-
plaints of membrane rupture were evident in all
patients. The mean age was 28.5 year old. Half of
them were in their first pregnancy (50%). Mean
age during presentation was 35.5 ± 3.4 weeks of
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Nitrazine
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Figure 1. Schematic representation of study scheme.
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gestation. Positive vaginal pooling and nitrazine
test was found in 14 patients (70%) and 13 (65%)
patients respectively. 
Table 1. Comparison of Amnisure® results and Nitrazine
test.
Amnisure
Nitrazine test Positive Negative Total
Positive 12 1 13
Negative  2 5  7
Total 14 6 20
Amnisure® was found positive in 14 patients.
The value for sensitivity, specificity, positive pre-
dictive value and negative predictive value were
calculated with nitrazine as standard for diagnosis
of membrane rupture; with tabulation seen in Ta-
ble 1. With nitrazine as standard for ROM diagno-
sis, the sensitivity for Amnisure® was 85% and the
specificity was 83.3%. The positive predictive value
was 92.3% and negative predictive value was
71.4%.
Table 2. Results of Amnisure® and diagnosis rupture of
membrane (ROM).
Amnisure
ROM Positive Negative Total
Evident 14 2 16
Non Evident  0 4  4
Total 14 6 20
Patients with positive vaginal pooling will result
in positive nitrazine and Amnisure® test (14 pa-
tients). One exceptional case is one patient with
negative nitrazine and vaginal pooling but positive
Amnisure test.
DISCUSSION
Placental alpha micro-globulin 1 (PAMG-1) was first
described by dr. D. Petrunin in 1975. It was derived
from amniotic fluid. PAMG-1 is a 34-kd protein. It
has unique features, which is a high concentration
in amniotic fluid, low levels in blood and extremely
low levels in cervicovaginal secretions with intact
fetal membranes. Baseline level of PAMG-1 with
presence of vaginitis or an admixture of blood or
serum will rarely reach 3 ng/ml maximum. Con-
centration ranges of PAMG-1 in amniotic fluid are
2,000 to 25,000 ng/ml. The Amnisure® test em-
ploys monoclonal antibodies to detect minute
amount of PAMG-1. Sensitivity threshold for PAMG-1
with Amnisure® is 5 ng/ml. Thus, reducing the
probability for false positive and false negative results.
Several studies have tested the robustness of
PAMG-1 with other methods for membrane rup-
ture. Cousins et al measured Amnisure® on 203 pa-
tients with suspected ruptured membranes and
found 90 patients were positive.13 They claimed
that sensitivity and specificity of the test to be
98.9% and 100% respectively. Mittal and Romero
reviewed the usage of Amnisure® in 113 pregnant
women with sonographically short cervix. They
found that patients with positive test had a shorter
admission-to-SROM (spontaneous rupture of mem-
brane) interval than those with a negative test (43
days versus 78 days, p value 0.02).14 They sug-
gested that the presence of PAMG-1 in vaginal fluid
is indicative of micro-perforations of intact mem-
branes. Similar conclusion was taken by Lee et al
which conducted Amnisure® testing for women
with and without intact membrane.15 Patients with
positive Amnisure® test had a shorter admission-to-
delivery interval than those with negative results.
Our study design was similar with Lee et al.16
They conducted a prospective observational study
from March 2005 till February 2006. From 184 pa-
tients recruited in their series, conventional diag-
nostic method of membrane rupture resulted in
76% diagnosis at initial presentation. Amnisure®
confirmed initial diagnosis of membrane rupture
with sensitivity of 98.7%, specificity 87.5%, posi-
tive predictive value of 98.1% and negative predic-
tive value of 91.3%. It seemed appreciable to note
that for every patient in our series with positive
vaginal pooling, test for nitrazine and Amnisure®
will be positive. This is relevant with guidelines
from RCOG, in which history taking and sterile
speculum examination will usually suffice to deter-
mine membrane rupture.11 In cases which diagno-
sis of membrane rupture is un-debatable, role of
other methods such as Amnisure® seemed ques-
tionable. However, rarely, we will find conditions
such as long standing membrane rupture, un-
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known causes of oligohydramnios or ROM too se-
vere to cause any fluid to leak again from uterine
cavity. Presence of PAMG-1 in these cases will re-
solve the issue of whether ROM occurred or not.
Indeed, in our study, only one patient had negative
vaginal pooling and nitrazine test but positive Am-
nisure® test. The patient admitted having sensa-
tion of fluid leaking out and had severe oligohy-
dramnios during ultrasound exam. The baby was
delivered healthy, with nil amniotic fluid. Presence
of infection was proven with increased leucocyte
esterase level from cervicovaginal secretion.
CONCLUSION
To our knowledge, this is the first study to evaluate
the usage of PAMG-1 identification for diagnosis of
ROM in Indonesia. Given the natural burden of
ROM, especially premature ROM (PROM) and pre-
term PROM (PPROM), a standardized method with
excellent sensitivity and specificity is needed for us
to firmly diagnose membrane rupture. In obvious
cases, Amnisure® test seemed less likely to be
needed. However, in some cases, presence of
PAMG-1 may be of great aid in determining diag-
nosis. Support for evidence of micro-perforation in
a seemingly intact membrane with positive Am-
nisure® test needs further research and evalu-
ations. More study is necessary before we can ap-
ply this method in Indonesia, especially when deal-
ing with cost effectiveness analysis.
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